Page 48 - FINAL PROGRAM

MONDAY, 4 JULY 2016
10:00 - 11:30 Room 101
Session 07: Optimizing ovarian stimulation
10:00 O-033
10:15 O-034
10:30 O-035
10:45 O-036
11:00 O-037 11:15 O-038
Results of the ESPART randomized controlled trial investigating recombinant luteinizing hormone supplementation for controlled ovarian stimulation in poor ovarian responders aligned with the Bologna criteria
P. Humaidan (Denmark)
Are AMH level and AFC useful predictors of outcomes in poor ovarian responders? A post hoc analysis of the ESPART randomized controlled trial
J. Hubbard (U.S.A.)
Optimization of outcome through individualized dosing in predicted poor responders undergoing IVF/ICSI; the OPTIMIST randomized controlled trial, NTR2657
C. van Tilborg (The Netherlands)
Optimization of outcome through individualized dosing in predicted hyper responders undergoing IVF/ICSI; The OPTIMIST randomized controlled trial, NTR2657
S. Oudshoorn (The Netherlands)
Cost-effectiveness of ovarian reserve testing in an IVF program; the OPTIMIST study
H. Torrance (The Netherlands)
Testosterone pre-treatment in poor responders treated with GnRH analogues and gonadotrophins for in-vitro fertilization: a meta-analysis
J. Bosdou (Greece)
44